<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig4">
 <label>Figure 4</label>
 <caption>
  <p>MERS-CoV RBD in trimeric form with MF59 protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection. (A) Schematic structure of MERS-CoV S1 subunit and construction of RBD-Fd. A His6 tag was added at the C-terminus of RBD-Fd (B) MERS-CoV S1-specific IgG antibody titers. (C) and (D) MERS-CoV S1-specific IgG1 and IgG2a antibody titers. (E) and (F) neutralizing antibody levels against infections of pseudotyped and live MERS-CoV of EMC2012 strain. (G) Survival rate of MERS-CoV infected mice after vaccination. Fd: foldon. The figure was adapted with permission from ref. 104. Copyright Â© 2017 Elsevier.</p>
 </caption>
 <alt-text id="alttext0030">Figure 4</alt-text>
 <graphic xlink:href="gr4_lrg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
